Back

Long-term cardiovascular morbidity and mortality after maternal heart failure: a nationwide population-based cohort study

30 August 2026 (16:33 - 16:45)
Organised by: Logo
Congress Presentation Part of: High-risk pregnancy and maternal cardiovascular vulnerability: disparities, prediction, and prevention Pregnancy and Cardiovascular Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Clara Kihlborg

Karolinska Institute, Stockholm (Sweden)

4 More presentations in this session

Presentation thumbnail
Association between aspirin use before 16 weeks of gestation and early postpartum cardiometabolic risk: an electronic health record–based study
Miss J. Li (Tianjin, CN)
Abstract
Presentation thumbnail
Food insecurity increases risk for peripartum cardiomyopathy and early presentation
Doctor K. Sompel (Aurora, US)
Abstract
Presentation thumbnail
Racial disparities in severe maternal morbidity among peripartum cardiomyopathy deliveries
Mr I. Bolad (Indiana, US)
Abstract
Presentation thumbnail
Pregnancy, in vitro fertilization and cardiovascular outcomes in women with hereditary thoracic aortic diseases compared to controls: a retrospective register-based matched case-control study
Professor J. Hlebowicz (Lund, SE)
Abstract

Access the full session

Session thumbnail
High-risk pregnancy and maternal cardiovascular vulnerability: disparities, prediction, and prevention

The Event

Event poster

ESC Congress 2026

30 August 2026 16:33 CET
You may be interested in
thumbnail
Congress Presentation
Long-term risk of mortality and heart failure hospitalization in patients with heart failure with and without autoimmune disease
22 May 2022
thumbnail
Congress Presentation
Long-term cardiovascular risk of pre-eclampsia
28 August 2023
thumbnail
Congress Presentation
Incidence and mortality of women diagnosed with peripartum cardiomyopathy from 1997 to 2019 in Sweden, national registry-based study.
29 August 2022
thumbnail
Congress Presentation
Pregnancy history and long-term progression of cardiomyopathy in LMNA genotype-positive women
11 December 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources